Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      United States In-Situ Hybridization Market 2018-2024

      Research and Markets Logo

      News provided by

      Research and Markets

      Apr 20, 2018, 08:45 ET

      Share this article

      Share this article


      DUBLIN, April 20, 2018 /PRNewswire/ --

      The "In Situ Hybridization: US Market Shares, Strategy, and Forecasts, 2018 to 2024" report from Wintergreen Research, Inc has been added to ResearchAndMarkets.com's offering.

      In Situ Hybridization: Technology Evolves To Provide Better Management of Diagnoses for Cancer, Infectous Disease, Chromosonal Abnormalities, Inflamatory Disease

      The US market for In Situ Hybridization (ISH) at $4.3 billion in 2017 and is anticipated to reach $7.8 billion by 2024, with CAGR of 7.8% in the next five years (2017 to 2024). Increasing diagnosis and growing incidence & prevalence of cancer, technology advancements in therapeutics, increasing government initiatives globally are expected to drive the growth of the market in the coming years.

      US markets are poised to achieve continuing growth as In Situ Hybridization is used in diagnostic situations to analyze single cells inside tissue. Managing single cell diagnostics in real time, encouraging collaborative business efforts. Lowering transaction management costs is a key benefit.

      In situ hybridization (ISH) is a type of hybridization that uses a labeled complementary DNA, RNA or modified nucleic acids strand (i.e., probe) to localize a specific DNA or RNA sequence in a portion or section of tissue (in situ), or, if the tissue is small enough (e.g., plant seeds, Drosophila embryos), in the entire tissue (whole mount ISH), in cells, and in circulating tumor cells (CTCs).

      Advances in RNA in situ hybridization transform molecular detection with morphological context enabling new applications. Scientists use RNA ISH to extract data dimensions. Immunohistochemistry (IHC) and RNA in situ Hybridization are widely used technologies sharing the unique capacity to analyze a marker at the single cell level while preserving the morphological context. In different situations, IHC and ISH are used in conjunction to validate data or provide complementary information.

      In situ hybridization (ISH) is a powerful technique for localizing specific nucleic acid targets within fixed tissues and cells, allowing users to obtain temporal and spatial information about gene expression and genetic loci. While the basic workflow of ISH is similar to that of blot hybridizationsthe nucleic acid probe is synthesized, labeled, purified, and annealed with the specific targetthe difference is the greater amount of information gained by visualizing the results within the tissue.

      Key Topics:

      • In Situ Hybridization
      • Molecular Diagnostics
      • Cervical Cancer Stain
      • Fish Steps Reduction
      • Fluorescence In Situ
      • Hybridization (FISH)
      • In Situ Hybridization (ISH)
      • FISH Probe Kit
      • Cancer
      • Chromosonal Abnormalities
      • Infectious Diseases
      • Inflammatory Diseases
      • Fluorescence In Situ
      • Hybridization (FISH)
      • Chromogenic In Situ
      • Hybridization (CISH)
      • Human Genetic Tests
      • Microbial Tests
      • In Vitro Diagnostics
      • System for the Analysis of Solid Tumors
      • Hybridization Technique
      • Detection of Long Non
      • Coding DNA
      • Coding RNA

      Key Topics Covered:

      1. US In situ Hybridization Executive Summary
      1.1 In Situ Hybridization (ISH)

      2. United States In Situ Hybridization ISH Market Definition and Market Dynamics
      2.1 US In situ Hybridization Market Overview
      2.1.1 Antibody Challenges and Validation
      2.2 Scope of In situ Hybridization in Inflammation
      2.2.1 RNAscope Applications

      3. In-Situ Hybridization Market Shares and Market Forecasts
      3.1 In-Situ Hybridization Market Driving Forces
      3.1.1 Identification of Cytokines and their Cellular Origins
      3.1.2 Detection of Long Non-Coding RNA (lncRNA) in Inflammatory Diseases
      3.1.3 Role of Inflammatory Pathways During Carcinogenesis
      3.1.4 Therapeutic Potential Of Secreted Proteins In Inflammatory Diseases
      3.1.5 Dual ISH-IHC Detect Cytokines During Inflammatory Responses
      3.2 In Situ Hybridization Market Shares
      3.2.1 Roche
      3.2.2 Abbott Molecular
      3.2.3 Advanced Cell Diagnostics
      3.2.4 PerkinElmer In Situ Hybridization Market Driving Forces
      3.2.5 In Situ Hybridization Market Shares, Unit Shipments and Kit Shipments
      3.3 In Situ Hybridization Market Forecasts
      3.3.5 In Situ Hybridization Market Segments, Units and Kits, Dollars and Percent, US,
      3.4 In situ Hybridization Market Segments
      3.4.1 In Situ Hybridization Market Shares, Dollars, Worldwide, 2012 to 2017
      3.4.2 Fluorescence (FISH) and Chromogenic (CISH) Detection
      3.4.3 ISH Applications
      3.4.4 Multiplex Fluorescence In Situ Hybridization (FISH)
      3.4.5 Fluorescence In Situ Hybridization (FISH)
      3.4.6 Cancer Drug Market
      3.4.7 Chronic Lymphocytic Leukemia (CLL)
      3.4.8 In-Situ Hybridization Cancer Diagnosis, Cytology, Infectious Disease Molecular Diagnostic
      3.1.6 In Situ Hybridization Market Segments, Diagnostic Laboratories, Academic & Research Institutes, Contract Research Organizations, and Pharmaceutical & Biotechnology Companies
      3.5 In-Situ Hybridization Pricing
      3.5.1 miRCURY LNA miRNA Detection Probes
      3.5.2 Price and Availability
      3.6 In-Situ Hybridization Geographical Analysis

      4. In-Situ Hybridization Research and Technology
      4.1 Hybridization Technique

      5. In-Situ Hybridization Company Profiles
      5.1 Abbott Laboratories
      5.1.1 Abbott Laboratories Market Categorization
      5.1.2 In Situ Hybridization Product Category, Application and Specification
      5.1.3 Abbott Laboratories Vysis Chronic Lymphocytic Leukemia (CLL) FISH Probe Kit (IVD)
      5.1.4 Vysis CLL FISH Probe Kit Contents
      5.1.5 Acupath Laboratories Test For Detecting Bladder Cancer Uses Probes from Abbott Molecular
      5.1.6 Abbott Laboratories Barrett's Esophagus FISH
      5.1.7 Abbott Molecular Vysis CLL FISH Probe Kit -
      5.1.8 Abbott Laboratories Revenue
      5.1.9 Abbott Laboratories ThermoBrite System
      5.1.10 Abbott Laboratories User Programmable Settings
      5.1.11 Abbott Laboratories Vysis FISH Chromosome Search
      5.1.12 Abbott Laboratories Molecular Diagnostics
      5.1.13 Abbott Diagnostic Products
      5.2 Acupath Laboratories
      5.2.1 Acupath Laboratories Barrett's Esophagus FISH
      5.3 Agilent Technologies
      5.3.1 Agilent CGH & CGH+SNP Microarrays
      5.3.2 Agilent Technologies Revenue
      5.3.3 Agilent Diagnostics and Genomics
      5.4 Bio-Techne / ACD
      5.4.1 Bio-Techne ACD RNAscope Widely Used In-Situ Hybridization Technique
      5.4.2 Bio-Techne Revenue
      5.4.3 Biotechne US Regional Analysis
      5.4.4 Advanced Cell Diagnostics
      5.5 F. Hoffmann-La Roche AG
      5.5.1 Roche Gene Amplification by Fluorescence In Situ Hybridization
      5.5.2 Roche Automated RNA isolation
      5.5.3 Roche Fluorescence In Situ Hybridization (FISH)
      5.5.4 Roche Agreement with Merck Millipore Sigma
      5.5.5 Roche Immuno Diagnostics
      5.5.6 F. Hoffmann-La Roche AG Revenue
      5.5.7 Roche Buys Flatiron Health Leader In Oncology-Specific Electronic Health Record (EHR) Software
      5.6 Danaher / Leica Biosystems Nussloch GmbH
      5.6.1 Leica Biosystems Nussloch GmbH BOND IHC/ISH Instruments
      5.6.2 Leica Biosystems Nussloch GmbH Revenue
      5.6.3 Danaher Geographical Revenue
      5.7 Thermo Fisher Scientific
      5.7.1 Thermo Fisher Scientific Fluorescence In Situ Hybridization (FISH)
      5.7.2 Chromogenic In Situ Hybridization (CISH)
      5.7.3 Thermo Fisher Scientific Revenue
      5.8 Merck KGaA
      5.9 PerkinElmer
      5.9.1 PerkinElmer Stain
      5.9.2 Perkin Elmer Revenue
      5.10 Qiagen / Exiqon A/S
      5.10.1 Qiagen's GeneReader NGS System
      5.10.2 Polygenetic Mutations Drive Cancer
      5.10.3 Qiagen Revenue
      5.11 BioGenex Laboratories
      5.11.1 BioGenex Fully-Automated Molecular Pathology Workstation
      5.11.2 BioGenex Boosts Genome Research and Diagnostics - BioGenex US
      5.11.3 BioGenex Antibodies for Cancer Diagnosis
      5.11.4 BioGenex PMS2 CK5
      5.11.5 eFISHiency System for the Analysis of Solid Tumors - BioGenex US
      5.12 Bio SB
      5.12.1 Bio SB Zytovision Molecular Diagnostics
      5.13 Bio-Techne / Advanced Cell Diagnostics (ACD)

      6. Summary and Conclusions
      6.1 Analyze A Marker At The Single Cell Level
      6.2 Advances in RNA In Situ Hybridization

      7. Appendix A: List Of Nucleic Acid-Based Tests
      7.1 List: Nucleic Acid-Based Tests Approved by US Center for Devices and Radiological Health
      7.1.1 List of Human Genetic Tests
      7.1.2 List of Microbial Tests
      7.2 In Vitro Diagnostics

      Companies Mentioned

      • Abbott Laboratories
      • Acupath Laboratories
      • Advanced Cell Diagnostics
      • Agilent Technologies
      • Bio SB Zytovision Molecular Diagnostics
      • Bio-Techne
      • BioGenex Laboratories
      • Biotechne US
      • Chromogenic In Situ Hybridization (CISH)
      • Danaher
      • Exiqon A/S
      • F. Hoffmann-La Roche AG
      • Leica Biosystems Nussloch GmbH
      • Merck KGaA
      • PerkinElmer
      • Qiagen
      • Roche Immuno Diagnostics
      • Thermo Fisher Scientific
      • Vysis

      For more information about this report visit https://www.researchandmarkets.com/research/7mzvjj/united?w=5

      Media Contact:

      Research and Markets
      Laura Wood, Senior Manager
      [email protected]

      For E.S.T Office Hours Call +1-917-300-0470
      For U.S./CAN Toll Free Call +1-800-526-8630
      For GMT Office Hours Call +353-1-416-8900

      U.S. Fax: 646-607-1907
      Fax (outside U.S.): +353-1-481-1716

      SOURCE Research and Markets

      Modal title

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.